Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies

Summary Generation of potent antibodies by a mutation-selection process called affinity maturation is a key component of effective immune responses. Antibodies that protect against highly mutable pathogens must neutralize diverse strains. Developing effective immunization strategies to drive their evolution requires understanding how affinity maturation happens in an enviroment where variants of the same antigen are present. We present an in silico model of affinity maturation driven by antigen variants which reveals that induction of cross-reactive antibodies often occurs with low probability because conflicting selection forces, imposed by different antigen variants, can frustrate affinity maturation. We describe how variables such as temporal pattern of antigen administration influence the outcome of this frustrated evolutionary process. Our calculations predict, and experiments in mice with variant gp120 constructs of the HIV envelope protein confirm, that sequential immunization with antigen variants is preferred over a cocktail for induction of cross-reactive antibodies focused on the shared CD4 binding site epitope.

[1]  C. Berek,et al.  Maturation of the immune response in germinal centers , 1991, Cell.

[2]  R C Stevens,et al.  Structural insights into the evolution of an antibody combining site. , 1997, Science.

[3]  C. Milstein,et al.  Mutation Drift and Repertoire Shift in the Maturation of the Immune Response , 1987, Immunological reviews.

[4]  M. Neuberger,et al.  Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate. , 1998, Immunity.

[5]  Dagmar Iber,et al.  An analysis of B cell selection mechanisms in germinal centers. , 2006, Mathematical medicine and biology : a journal of the IMA.

[6]  Peter D. Kwong,et al.  The antigenic structure of the HIV gp120 envelope glycoprotein , 1998, Nature.

[7]  C. Kocks,et al.  Stepwise intraclonal maturation of antibody affinity through somatic hypermutation. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Shlomchik,et al.  Clone: a Monte-Carlo computer simulation of B cell clonal expansion, somatic mutation, and antigen-driven selection. , 1998, Current topics in microbiology and immunology.

[9]  T. Leanderson,et al.  Somatic Mutation of Immunoglobulin V Genes in Vitro , 1996, Science.

[10]  D. Baker,et al.  Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant , 2011, PloS one.

[11]  Peter D. Kwong,et al.  HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites , 2002, Nature.

[12]  Mario Roederer,et al.  Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 , 2010, Science.

[13]  M. Shlomchik,et al.  Germinal centers , 2012, Immunological reviews.

[14]  Michael W Deem,et al.  Sequence space localization in the immune system response to vaccination and disease. , 2003, Physical review letters.

[15]  C. Milstein,et al.  Codon bias targets mutation , 1995, Nature.

[16]  Michael Meyer-Hermann,et al.  Germinal Center Dynamics Revealed by Multiphoton Microscopy with a Photoactivatable Fluorescent Reporter , 2010, Cell.

[17]  J. Sodroski,et al.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.

[18]  P Nieuwenhuis,et al.  Functional anatomy of germinal centers. , 1984, The American journal of anatomy.

[19]  Wayne M Patrick,et al.  User-friendly algorithms for estimating completeness and diversity in randomized protein-encoding libraries. , 2003, Protein engineering.

[20]  John P. Moore,et al.  Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer , 2013, Science.

[21]  Feng Gao,et al.  Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies , 2014, Cell.

[22]  John P. Moore,et al.  Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer , 2013, Science.

[23]  Young Do Kwon,et al.  Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility , 2009, Proceedings of the National Academy of Sciences.

[24]  J. Mascola,et al.  Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning , 2013, Nature Reviews Immunology.

[25]  Can Keşmir,et al.  A spatial model of germinal center reactions: cellular adhesion based sorting of B cells results in efficient affinity maturation. , 2003, Journal of theoretical biology.

[26]  Martin A. Nowak,et al.  Antibody neutralization and escape by HIV-1 , 2003, Nature.

[27]  G. Kelsoe,et al.  The germinal center: a crucible for lymphocyte selection. , 1996, Seminars in immunology.

[28]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[29]  N. Haigwood,et al.  Sequential Immunization with a Subtype B HIV-1 Envelope Quasispecies Partially Mimics the In Vivo Development of Neutralizing Antibodies , 2011, Journal of Virology.

[30]  D. Calado,et al.  Germinal Centers , 2017, Methods in Molecular Biology.

[31]  Tongqing Zhou,et al.  Structure and immune recognition of trimeric prefusion HIV-1 Env , 2014, Nature.

[32]  K Dane Wittrup,et al.  Isolating and engineering human antibodies using yeast surface display , 2006, Nature Protocols.

[33]  H. Eisen,et al.  VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE. , 1964, Biochemistry.

[34]  Eugene I. Shakhnovich,et al.  Optimality of Mutation and Selection in Germinal Centers , 2010, PLoS Comput. Biol..

[35]  Dennis R. Burton,et al.  Hyperglycosylated Mutants of Human Immunodeficiency Virus (HIV) Type 1 Monomeric gp120 as Novel Antigens for HIV Vaccine Design , 2003, Journal of Virology.

[36]  Tongqing Zhou,et al.  Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 , 2010, Science.

[37]  Thomas B. Kepler,et al.  Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation , 2014, Front. Immunol..

[38]  Adam Godzik,et al.  A Blueprint for HIV Vaccine Discovery. , 2012, Cell host & microbe.

[39]  P. Sharp,et al.  Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation , 1992, Journal of virology.

[40]  Holly Janes,et al.  Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies , 2009, Journal of Virology.

[41]  D R Burton,et al.  A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Florian Klein,et al.  Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy , 2014, Cell.

[43]  S. Targ,et al.  T Follicular Helper Cell Dynamics in Germinal Centers , 2013, Science.

[44]  D. Roopenian,et al.  Efficient Mucosal Delivery of Vaccine Using the FcRn-Mediated IgG Transfer Pathway , 2011, Nature Biotechnology.

[45]  Pham Phung,et al.  Broad neutralization coverage of HIV by multiple highly potent antibodies , 2011, Nature.

[46]  Michael Meyer-Hermann,et al.  A mathematical model for the germinal center morphology and affinity maturation. , 2002, Journal of theoretical biology.

[47]  W. Paul,et al.  The effect of antigen dose and time after immunization on the amount and affinity of anti-hapten antibody. , 1968, Journal of immunology.

[48]  David Harel,et al.  The Lymph Node B Cell Immune Response: Dynamic Analysis In-Silico , 2008, Proceedings of the IEEE.

[49]  F. Sallusto,et al.  Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. , 2013, Immunity.

[50]  Jason G. Cyster,et al.  Imaging of Germinal Center Selection Events During Affinity Maturation , 2007, Science.

[51]  G. Kelsoe,et al.  In situ studies of the primary immune response to (4-hydroxy-3- nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations , 1991, The Journal of experimental medicine.

[52]  J. Sodroski,et al.  Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein , 1992, Journal of virology.

[53]  B. Haynes,et al.  HIV‐1 neutralizing antibodies: understanding nature's pathways , 2013, Immunological reviews.

[54]  Chaim A. Schramm,et al.  Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus , 2013, Nature.

[55]  T. Kepler,et al.  Somatic hypermutation in B cells: an optimal control treatment. , 1993, Journal of theoretical biology.

[56]  Tongqing Zhou,et al.  Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120 , 2009, Science.

[57]  N. Haigwood,et al.  Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially. , 2012, Vaccine.

[58]  L. Stamatatos,et al.  Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope. , 2010, Structure.

[59]  R. Doms,et al.  Comparing Antigenicity and Immunogenicity of Engineered gp120 , 2005, Journal of Virology.

[60]  D. Irvine,et al.  Rapid conformational epitope mapping of anti-gp120 antibodies with a designed mutant panel displayed on yeast. , 2012, Journal of molecular biology.

[61]  A S Perelson,et al.  Somatic mutation leads to efficient affinity maturation when centrocytes recycle back to centroblasts. , 1997, Journal of immunology.

[62]  D R Burton,et al.  Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. , 1994, Science.

[63]  Tongqing Zhou,et al.  Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization , 2013, Cell.

[64]  Andrew E. Firth,et al.  Statistics of protein library construction , 2005, Bioinform..

[65]  F. Kroese,et al.  Germinal centers develop oligoclonally , 1987, European journal of immunology.